Pendal Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.29M | Buy |
1,733,391
+362,634
| +26% | +$689K | 0.03% | 181 |
|
|
2022
Q3 | $2.93M | Buy |
1,370,757
+5,328
| +0.4% | +$11.4K | 0.03% | 176 |
|
|
2022
Q2 | $3.86M | Sell |
1,365,429
-9,677
| -0.7% | -$27.4K | 0.04% | 152 |
|
|
2022
Q1 | $5.73M | Sell |
1,375,106
-69,696
| -5% | -$291K | 0.05% | 141 |
|
|
2021
Q4 | $7.5M | Buy |
1,444,802
+36,485
| +3% | +$189K | 0.06% | 127 |
|
|
2021
Q3 | $9.23M | Buy |
1,408,317
+875,067
| +164% | +$5.73M | 0.08% | 119 |
|
|
2021
Q2 | $4.6M | Buy |
533,250
+411,685
| +339% | +$3.55M | 0.04% | 151 |
|
|
2021
Q1 | $1.05M | Buy |
121,565
+71,211
| +141% | +$614K | 0.01% | 313 |
|
|
2020
Q4 | $450K | Buy |
+50,354
| New | +$450K | ﹤0.01% | 384 |
|